Academician TONG Xiaolin's Understanding and Experience in Treating Severe Cases of COVID-19

TIAN Chuanxi; YANG Yingying; SUN Aru; ZHAO Xuefei; ZHANG Yanjiao; LI Qingwei; XUE Chongxiang; HAO Rui; WANG Qiang; ZHU Wei

doi:10.13288/j.11-2166/r.2023.23.013

您当前的位置：

首页 >

文章列表页 >

Academician TONG Xiaolin's Understanding and Experience in Treating Severe Cases of COVID-19

更新时间：2023-11-24

- Academician TONG Xiaolin's Understanding and Experience in Treating Severe Cases of COVID-19
- Journal of Traditional Chinese Medicine Vol. 64, Issue 23, Pages: 2454-2456(2023)
- 作者机构：
  
  1.北京中医药大学，北京市朝阳区北三环东路11号，100029
  2.中国中医科学院广安门医院
  3.中日友好医院
  4.长春中医药大学
  5.东北国际医院
  6.中国人民解放军联勤保障部队第九四二医院
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2023.23.013
  CLC：
- Received：03 April 2023，
  
  Revised：2023-09-18，
  
  Published：02 December 2023
- 稿件说明：
移动端阅览
田传玺,杨映映,孙阿茹等.仝小林对新型冠状病毒感染重症的认识和辨治经验[J].中医杂志,2023,64(23):2454-2456.

TIAN Chuanxi,YANG Yingying,SUN Aru,et al.Academician TONG Xiaolin's Understanding and Experience in Treating Severe Cases of COVID-19[J].Journal of Traditional Chinese Medicine,2023,64(23):2454-2456.
田传玺,杨映映,孙阿茹等.仝小林对新型冠状病毒感染重症的认识和辨治经验[J].中医杂志,2023,64(23):2454-2456. DOI： 10.13288/j.11-2166/r.2023.23.013.

TIAN Chuanxi,YANG Yingying,SUN Aru,et al.Academician TONG Xiaolin's Understanding and Experience in Treating Severe Cases of COVID-19[J].Journal of Traditional Chinese Medicine,2023,64(23):2454-2456. DOI： 10.13288/j.11-2166/r.2023.23.013.

摘要

总结仝小林院士治疗新型冠状病毒感染重症的临床经验，为中西医结合救治新型冠状病毒感染重型和危重型患者提供治疗思路。认为新型冠状病毒感染属中医学“寒湿疫”，病因为寒湿戾气，病程分为郁、闭、脱、虚四个阶段，重症主要处于“闭”和/或“脱”二期。新型冠状病毒感染“闭”期病机为疫毒闭肺，治当宣肺通腑、化痰通络，以子龙宣白承气汤为主方加减治疗；“脱”期病机为内闭外脱，治当回阳救逆、益气固脱、宣肺通腑、化痰通络，以破格子龙宣白承气汤为主方加减治疗。

Abstract

This article highlighted the invaluable expertise of Academician TONG Xiaolin in managing severe cases of COVID-19， thereby providing ideas for the treatment of severe and critically ill patients with SARS-CoV-2 infection by integrating traditional Chinese and western medicine. It is believed that COVID-19 belongs to the “cold dampness epidemic” in traditional Chinese medicine， which is caused by pathogenic qi of cold and dampness. The course of the disease can be divided into four stages： constraint， block， collapse， and deficiency， and the severe cases are mainly in the block and collapse stages. The pathogenesis at the block stage is described as epidemic toxins blocking the lung， which should be treated by diffusing the lung and unblocking the bowels， resolving phlegm and unblocking collaterals. The primary formula used is

Zilong Xuanbai Chengqi Decoction （

子龙宣白承气汤） with modifications based on individual condition. The pathogenesis at the collapse stage is described as internal block and external collapse， which should be treated by restoring yang to save from collapse， boosting qi to relieve collapse， diffusing the lung and unblocking the bowels， resolving phlegm and unblocking collaterals， usually with the formula

Poge Zilong Xuanbai Chengqi Decoction （

破格子龙宣白承气汤） with modifications.

关键词

Keywords

references

KANG X ， JIN D ， JIANG L ， et al . Efficacy and mechanisms of traditional Chinese medicine for COVID-19： a systematic review ［J］. Chin Med ， 2022 ， 17 （ 1 ）： 30 . doi： 10.1186/S13020-022-00587-7 http://dx.doi.org/10.1186/S13020-022-00587-7 .

ZHUANG J ， DAI X ， ZHANG W ， et al . Efficacy and safety of integrated traditional Chinese and Western medicine against COVID-19： a systematic review and meta-analysis ［J］. Phytother Res ， 2022 ， 36 （ 12 ）： 4371 - 4397 .

刘永江 . 西医联合化湿败毒方治疗重型新型冠状病毒肺炎的临床疗效分析［J］. 检验医学与临床， 2021 ， 18 （ 8 ）： 1152 - 1153 .

ZHOU S ， FENG J ， XIE Q ， et al . Traditional Chinese medicine shenhuang granule in patients with severe/critical COVID-19： a randomized controlled multicenter trial ［J］. Phytomedicine ， 2021 89 ： 153612 . doi： 10.1016/j.phymed. 2021.153612 http://dx.doi.org/10.1016/j.phymed.2021.153612 .

LI Q ， WANG H ， LI X ， et al . The role played by traditional Chinese medicine in preventing and treating COVID-19 in China ［J］. Front Med ， 2020 ， 14 （ 5 ）： 681 - 688 .

杨映映，丁齐又，宋斌，等 . 论“戾嗜”在疫病辨治中的价值［J］. 中医杂志， 2022 ， 63 （ 15 ）： 1401 - 1405 .

仝小林，李修洋，赵林华，等 . 从“寒湿疫”角度探讨新型冠状病毒肺炎的中医药防治策略［J］. 中医杂志， 2020 ， 61 （ 6 ）： 465 - 470，553 .

杨映映，李青伟，鲍婷婷，等 . 仝小林院士辨治新型冠状病毒肺炎：“寒湿疫”辨治体系的形成、创新与发展［J］. 世界中医药， 2022 ， 17 （ 6 ）： 833 - 837，842 .

黄延芳，贺雅琪，谭剑文 . 破格救心汤治疗急性心力衰竭的应用探析［J］. 中国中医急症， 2016 ， 25 （ 3 ）： 443 - 444，467 .

鲍婷婷，杨映映，黄飞剑，等 . 论寒湿疫之瘀热入营［J］. 中医杂志， 2021 ， 62 （ 8 ）： 645 - 649 .

董立硕，李青伟，张莉莉，等 . 基于态靶辨治选方用药的思路与临床应用［J］. 中医杂志， 2023 ， 64 （ 3 ）： 250 - 254 .

魏秀秀，苟筱雯，赵林华，等 . 态靶辨证在肝胃郁热型肥胖2型糖尿病中的运用：大柴胡汤加黄连、知母、赤芍［J］. 辽宁中医杂志， 2020 ， 47 （ 3 ）： 1 - 3 .

顾成娟，杨才佳，王涵 . 仝小林使用天花粉、知母、葛根降糖经验［J］. 吉林中医药， 2021 ， 41 （ 4 ）： 458 - 460 .

杨浩宇，王新苗，顾成娟，等 . 茵陈、赤芍、金钱草治疗胆汁淤积及转氨酶升高经验：仝小林三味小方撷萃［J］. 吉林中医药， 2020 ， 40 （ 1 ）： 18 - 20 .

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

The Development of Chinese Herbal Formulae for Non-severe COVID-19 Based on Artificial Intelligence Technology and Investigation of Its Action Mechanisms

Integrated Traditional Chinese and Western Medicine Treatment for Acute Lymphoblastic Leukemia Complicated with Severe COVID-19 in Recovery Stage： A Case Report

Integration of Traditional Chinese and Western Medicine in the Treatment of Liver Transplant Patient with Severe COVID-19： A Case Report

Treatment of Critical COVID-19 Case Complicated with Multiple Organ Dysfunction based on “Cold-dampness Entering Ying （营）” Theory： A Case Report

Contribution of Traditional Chinese Medicine Combined with Conventional Medicine Treatment for a Long-Term Survivor of Heart Transplant with Severe COVID-19： A Case Report

Related Author

LIU Qingquan

HUANG Wenting

QIAO Liansheng

YAN Di

LIU Tengwen

CAO Hongmei

GUO Hongyan

ZHANG Zhi

Related Institution

Beijing Hospital of Traditional Chinese Medicine，Capital Medical University

Beijing CapitalBio Pharma Co.， Ltd.

School of Basic Medical Sciences，Chengdu University of Traditional Chinese Medicine

National Engineering Research Center for Beijing Biochip Technology

Medical Systems Biology Research Center， School of Medicine， Tsinghua University

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰